An Expert Roundtable Discussion on the Use of Classic Monoamine Oxidase Inhibitors in the Treatment of Depression-Part Two

被引：1

作者：

Berk, Michael ^{[1
,2
,3
]}

Van den Eynde, Vincent ^{[4
,5
,6
,24
]}

Ganapathy, Karthikeyan ^{[7
]}

Andrade, Chittaranjan ^{[8
]}

Birkenhager, Tom ^{[9
,10
]}

Bodkin, J. Alexander ^{[11
,12
]}

Nutt, David ^{[13
,14
]}

Barnett, Brian ^{[15
]}

Feinberg, Simeon Shalom ^{[16
,17
]}

Parker, Gordon ^{[18
,19
]}

Ruhe, Eric ^{[20
,21
]}

Fornaro, Michele ^{[22
]}

Redhead, Charles ^{[4
,5
,23
]}

Godet, Lila ^{[4
,5
]}

Gillman, Peter Kenneth ^{[4
,5
]}

机构：

[1] Deakin Univ, Geelong, Australia

[2] Barwon Hlth, Geelong, Australia

[3] Inst Innovat Mental & Phys Hlth & Clin Translat IM, Geelong, Vic, Australia

[4] PsychoTrop Res, Bucasia, Qld, Australia

[5] Int MAOI Expert Grp, Bucasia, Qld, Australia

[6] RadboudUMC, Dept Psychiat, Nijmegen, Netherlands

[7] Envis Mind Care, Edmonton, AB, Canada

[8] Natl Inst Mental Hlth & Neurosci, Bangalore, India

[9] Erasmus MC, Dept Depress Disorders, Rotterdam, Netherlands

[10] Univ Antwerp, Antwerp, Belgium

[11] McLean Hosp, Belmont, MA USA

[12] Harvard Med Sch, Boston, MA USA

[13] Imperial Coll London, Fac Med, Dept Brain Sci, London, England

[14] DrugSci, London, England

[15] Cleveland Clin, Cleveland, OH USA

[16] Albert Einstein Coll Med, Dept Psychiat & Behav Sci, New York, NY USA

[17] Montefiore Med Ctr, New York, NY USA

[18] Univ New South Wales, Fac Med & Hlth, Sch Psychiat, Sydney, NSW, Australia

[19] Gordon Private Hosp, Sydney, Australia

[20] RadboudUMC, Nijmegen, Netherlands

[21] Donders Ctr, Nijmegen, Netherlands

[22] Midwestern Univ, Downers Grove, IL USA

[23] Univ New South Wales, Fac Med & Hlth, Sch Biomed Sci, Sydney, NSW, Australia

[24] PsychoTrop Res, POB 86 Rural View, Bucasia, Qld 4740, Australia

来源：

PSYCHIATRIC ANNALS | 2023年 / 53卷 / 08期

关键词：

ANTIDEPRESSANTS;

D O I：

10.3928/00485713-20230718-01

中图分类号：

R749 [精神病学];

学科分类号：

100205 ;

摘要：

Experienced clinicians and academics from the International MAOI Expert Group comment on questions of interest concerning monoamine oxidase inhibitor (MAOI) pharmacotherapy for depression. These comments in this Part Two of the Expert Roundtable Discussion emphasize good pharmacological practice, starting with a low dose and progressing slowly and only changing one element at a time. Issues related to augmentation and drug combinations are also mentioned, including comments about the safety of ketamine. The special ability of MAOIs to improve dopamine function is highlighted, especially in relation to melancholic and psychotic depression. [Psychiatr Ann. 2023;53(8):364-369.]

引用

页码：364 / 369

页数：6

共 13 条

[1] Is dose escalation of antidepressants a rational strategy after a medium-dose treatment has failed? A systematic review [J].

Adli, M ;

Baethge, C ;

Heinz, A ;

Langlitz, N ;

Bauer, M .

EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE, 2005, 255 (06) :387-400

[2] Ketamine for Depression, 5: Potential Pharmacokinetic and Pharmacodynamic Drug Interactions [J].

Andrade, Chittaranjan .

JOURNAL OF CLINICAL PSYCHIATRY, 2017, 78 (07) :E858-E861

[3]

Berk M., World Psychiatry

[4] Combining stimulants with monoamine oxidase inhibitors: A review of uses and one possible additional indication [J].

Feinberg, SS .

JOURNAL OF CLINICAL PSYCHIATRY, 2004, 65 (11) :1520-1524

[5] A review of serotonin toxicity data: Implications for the mechanisms of antidepressant drug action [J].

Gillman, P. Ken .

BIOLOGICAL PSYCHIATRY, 2006, 59 (11) :1046-1051

[6] Findings From World Mental Health Surveys of the Perceived Helpfulness of Treatment for Patients With Major Depressive Disorder [J].

Harris, Meredith G. ;

Kazdin, Alan E. ;

Chiu, Wai Tat ;

Sampson, Nancy A. ;

Aguilar-Gaxiola, Sergio ;

Al-Hamzawi, Ali ;

Alonso, Jordi ;

Altwaijri, Yasmin ;

Andrade, Laura Helena ;

Cardoso, Graca ;

Cia, Alfredo ;

Florescu, Silvia ;

Gureje, Oye ;

Hu, Chiyi ;

Karam, Elie G. ;

Karam, Georges ;

Mneimneh, Zeina ;

Navarro-Mateu, Fernando ;

Oladeji, Bibilola D. ;

O'Neill, Siobhan ;

Scott, Kate ;

Slade, Tim ;

Torres, Yolanda ;

Vigo, Daniel ;

Wojtyniak, Bogdan ;

Zarkov, Zahari ;

Ziv, Yuval ;

Kessler, Ronald C. .

JAMA PSYCHIATRY, 2020, 77 (08) :830-841

[7] Antiparkinsonian drug-induced sleepiness: a double-blind placebo-controlled study of L-dopa, bromocriptine and pramipexole in healthy subjects [J].

Micallef, Joelle ;

Rey, Marc ;

Eusebio, Alexandre ;

Audebert, Christine ;

Rouby, Frank ;

Jouve, Elisabeth ;

Tardieu, Sophie ;

Blin, Oliver .

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2009, 67 (03) :333-340

[8] A systematic review and meta-analysis of lithium augmentation of tricyclic and second generation antidepressants in major depression [J].

Nelson, J. Craig ;

Baumann, Pierre ;

Delucchi, Kevin ;

Joffe, Russell ;

Katona, Cornelius .

JOURNAL OF AFFECTIVE DISORDERS, 2014, 168 :269-275

[9] COMMON SIDE-EFFECTS ASSOCIATED WITH MONOAMINE-OXIDASE INHIBITORS [J].

REMICK, RA ;

FROESE, C ;

KELLER, FD .

PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY, 1989, 13 (3-4) :497-504

[10] Safety of Ketamine Augmentation to Monoamine Oxidase Inhibitors in Treatment-Resistant Depression: A Systematic Literature Review and Case Series [J].

Veraart, Jolien K. E. ;

Smith-Apeldoorn, Sanne Y. ;

Kutscher, Mats ;

Vischjager, Maurice ;

van der Meij, Annemarie ;

Kamphuis, Jeanine ;

Schoevers, Robert A. .

JOURNAL OF CLINICAL PSYCHIATRY, 2022, 83 (06)

← 1 2 →